Cargando…

Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis

PURPOSE OF REVIEW: Non-steroidal exacerbated respiratory disease (N-ERD) currently requires aspirin challenge testing for diagnosis. Urinary leukotriene E4 (uLTE(4)) has been extensively investigated as potential biomarker in N-ERD. We aimed to assess the usefulness of uLTE(4) as a biomarker in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marquette, Malcolm, Tailor, Bhavesh V., Calder, Philip C., Curtis, Peter J., Loke, Yoon, Wilson, Andrew M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Asthma (V Ortega, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732072/ https://www.ncbi.nlm.nih.gov/pubmed/36374376 http://dx.doi.org/10.1007/s11882-022-01049-8

Ejemplares similares

Structural and Social Determinants of Health in Asthma in Developed Economies: a Scoping Review of Literature Published Between 2014 and 2019
por: Sullivan, Kathryn, et al.
Publicado: (2020)

Using Telemedicine to Care for the Asthma Patient
por: Persaud, Yudy K.
Publicado: (2022)

Obesity, Inflammation, and Severe Asthma: an Update
por: Sharma, Varun, et al.
Publicado: (2021)

Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD
por: De Simón Gutiérrez, Raúl, et al.
Publicado: (2022)

Recent miRNA Research in Asthma
por: Sharma, Rinku, et al.
Publicado: (2022)

The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract
por: Pawełczyk, Malgorzata, et al.
Publicado: (2017)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023)

Influence of HIV status on the management of acute asthma exacerbations
por: Adrish, Muhammad, et al.
Publicado: (2019)

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
por: de Boer, Geertje, et al.
Publicado: (2021)

Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations
por: Chan, Rory, et al.
Publicado: (2022)

Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study
por: Soremekun, Seyi, et al.
Publicado: (2023)

Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD
por: Tepetam, Fatma Merve, et al.
Publicado: (2023)

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone
por: Bateman, Eric D, et al.
Publicado: (2014)

Core outcomes and factors influencing the experience of care for children with severe acute exacerbations of asthma: a qualitative study
por: Craig, Simon, et al.
Publicado: (2023)

Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data
por: Shah, Syed A, et al.
Publicado: (2021)

Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)
por: Tydeman, Florence, et al.
Publicado: (2023)

International perspective on research priorities and outcome measures of importance in the care of children with acute exacerbations of asthma: a qualitative interview study
por: Gray, Charmaine S, et al.
Publicado: (2023)

Sociodemographic factors associated with time to discharge for hospitalised patients with asthma and asthma exacerbation using the Ghana Health Service District Information Management System 2 (DHIMS-2) database, 2012–2017
por: Narh, Clement T, et al.
Publicado: (2021)

Development of a conceptual model of childhood asthma to inform asthma prevention policies
por: Adibi, Amin, et al.
Publicado: (2021)

Influence of asthma and obesity on respiratory symptoms, work ability and lung function: findings from a cross-sectional Norwegian population study
por: Klepaker, Geir, et al.
Publicado: (2021)

Among respiratory symptoms, wheeze associates most strongly with impaired lung function in adults with asthma: a long-term prospective cohort study
por: Bermúdez Barón, Nicolás, et al.
Publicado: (2021)

Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease
por: Rhyou, Hyo-In, et al.
Publicado: (2022)

Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)? 
por: Förster-Ruhrmann, Ulrike, et al.
Publicado: (2020)

Treatment patterns and frequency of key outcomes in acute severe asthma in children: a Paediatric Research in Emergency Departments International Collaborative (PREDICT) multicentre cohort study
por: Craig, Simon, et al.
Publicado: (2022)

Early Exacerbation Relapse is Increased in Patients with Asthma and Bronchiectasis (a Post hoc Analysis)
por: Hill, Andrew R., et al.
Publicado: (2023)

uPAR regulates bronchial epithelial repair in vitro and is elevated in asthmatic epithelium
por: Stewart, Ceri E, et al.
Publicado: (2011)

Risk factors for atopic and non-atopic asthma in a rural area of Ecuador
por: Moncayo, Ana Lucia, et al.
Publicado: (2010)

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
por: Heaney, Liam G, et al.
Publicado: (2010)

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes
por: Gupta, Sumit, et al.
Publicado: (2010)

Adverse effects of salmeterol in asthma: a neuronal perspective
por: Lommatzsch, M, et al.
Publicado: (2009)

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β(2) agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial
por: Busse, William W, et al.
Publicado: (2013)

Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction
por: Lazarinis, Nikolaos, et al.
Publicado: (2014)

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848
por: Delaney, Stephen, et al.
Publicado: (2016)

Three-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial use
por: Pilcher, Janine, et al.
Publicado: (2015)

Economic analysis of temperature-controlled laminar airflow (TLA) for the treatment of patients with severe persistent allergic asthma
por: Brazier, Peter, et al.
Publicado: (2016)

Effects of body mass index, tobacco smoking, alcohol drinking and solid fuel use on the risk of asthma: Individual Participant Data (IPD) meta-analysis of 175 000 individuals from 51 nationally representative surveys
por: Patra, Jayadeep, et al.
Publicado: (2016)

Factors associated with relapse in adult patients discharged from the emergency department following acute asthma: a systematic review
por: Hill, Jesse, et al.
Publicado: (2017)

Step 4: stick or twist? A review of asthma therapy
por: Slater, Mariel G, et al.
Publicado: (2016)

What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective
por: Howard, Sam, et al.
Publicado: (2016)

Differentiation of quantitative CT imaging phenotypes in asthma versus COPD
por: Choi, Sanghun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8lan0dot1dafisr433mbrfu830